Earnings call ASP Isotopes reported 18% YoY Q3 radiopharmaceutical revenue growth (excluding Skyline), with year-to-date radiopharma revenue up 24%. Operating expenses rose 84% YoY due to a 66% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results